These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 17466419

  • 1. TLR4-dependent adjuvant activity of Neisseria meningitidis lipid A.
    Zughaier S, Steeghs L, van der Ley P, Stephens DS.
    Vaccine; 2007 May 30; 25(22):4401-9. PubMed ID: 17466419
    [Abstract] [Full Text] [Related]

  • 2. Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway.
    Zughaier SM, Tzeng YL, Zimmer SM, Datta A, Carlson RW, Stephens DS.
    Infect Immun; 2004 Jan 30; 72(1):371-80. PubMed ID: 14688118
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.
    Fukasawa LO, Dias WO, Schenkman RP, Raw I, Tanizaki MM.
    FEMS Immunol Med Microbiol; 2004 Jul 01; 41(3):205-10. PubMed ID: 15196569
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of immunological responses to recombinant Porin A protein (rPoA) from native strains of Neisseria meningitidis serogroups A and B using OMV as an adjuvant in BALB/c mice.
    Afrough P, Bouzari S, Mousavi SF, Asadi Karam MR, Vaziri F, Fateh A, Behrouzi A, Malekan M, Siadat SD.
    Microb Pathog; 2017 Nov 01; 112():209-214. PubMed ID: 28942175
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
    Tunheim G, Arnemo M, Næss LM, Fjeldheim ÅK, Nome L, Bolstad K, Aase A, Mandiarote A, González H, González D, García L, Cardoso D, Norheim G, Rosenqvist E.
    Vaccine; 2013 Dec 09; 31(51):6097-106. PubMed ID: 24120679
    [Abstract] [Full Text] [Related]

  • 12. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
    Delgado M, Yero D, Niebla O, González S, Climent Y, Pérez Y, Cobas K, Caballero E, García D, Pajón R.
    Vaccine; 2007 Dec 05; 25(50):8420-31. PubMed ID: 17996338
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New proteoliposome vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potential as well as Th-1 adjuvant capacity.
    Tamargo B, Márquez Y, Ramírez W, Cedré B, Fresno M, Sierra G.
    BMC Immunol; 2013 Dec 05; 14 Suppl 1(Suppl 1):S12. PubMed ID: 23458443
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci.
    Jolley KA, Appleby L, Wright JC, Christodoulides M, Heckels JE.
    Infect Immun; 2001 Jun 05; 69(6):3809-16. PubMed ID: 11349046
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response.
    Steeghs L, Kuipers B, Hamstra HJ, Kersten G, van Alphen L, van der Ley P.
    Infect Immun; 1999 Oct 05; 67(10):4988-93. PubMed ID: 10496868
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.
    Findlow J, Taylor S, Aase A, Horton R, Heyderman R, Southern J, Andrews N, Barchha R, Harrison E, Lowe A, Boxer E, Heaton C, Balmer P, Kaczmarski E, Oster P, Gorringe A, Borrow R, Miller E.
    Infect Immun; 2006 Aug 05; 74(8):4557-65. PubMed ID: 16861642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.